(Q67649744)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

Effect of a long-acting somatostatin analogue (BIM23014) on proliferative diabetic retinopathy: a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference

proliferative diabetic retinopathy

1 reference

McCombe M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Lightman S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Eckland DJ

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Hamilton AM

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Lightman SL

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

5 ( Pt 5)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

569-575

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/eye.1991.99

16 September 2019

exact match

0 references

cites work

A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Retinopathy and plasma growth hormone levels in idiopathic hemochromatosis with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Recovery from retinopathy in a case of diabetes with Simmonds' disease

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Hypophysectomy in Diabetic Retinopathy: The Relationship Between the Degree of Pituitary Ablation and Ocular Response

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

The role of growth hormone in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Influence of muscular exercise on plasma level of growth hormone in diabetics with and without retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Rationale for inhibition of growth hormone secretion in the management of the diabetic patient

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Suppression of growth hormone and somatomedin C by long-acting somatostatin analog SMS 201-995 in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Clinical evaluation of somatostatin as a potential ajunct to insulin in the management of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Effects of the somatostatin analog BIM 23014 on the secretion of growth hormone, thyrotropin, and digestive peptides in normal men

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. The Diabetic Retinopathy Study Research Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Temporary loss of foveal contrast sensitivity associated with panretinal photocoagulation

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1991.99

7 January 2021

Identifiers

DOI

10.1038/EYE.1991.99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1686591%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

16 September 2019

0 references

1 reference